Evidence map›Paper›PMID 39363626›Full record

ArticleFuture medicinal chemistry2024

3,5-disubstituted pyridines with potent activity against drug-resistant

Komal G Sangu, Vijayan N Azger Dusthackeer, Vishal K Singh, Shivani Maykalwar, Eruva Vamshi Krishna, Balasubramanian Angayarkanni, Rahul Maitra, Sidharth Chopra, Sunil Misra, Haridas B Rode

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Komal G SanguDepartment of Natural Products & Medicinal Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.
Vijayan N Azger DusthackeerDepartment of Bacteriology, National Institute for Research in Tuberculosis, Chennai, 600 031, India.
Vishal K SinghDepartment of Natural Products & Medicinal Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.
Shivani MaykalwarDepartment of Natural Products & Medicinal Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.
Eruva Vamshi KrishnaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201 002, India.
Balasubramanian AngayarkanniDepartment of Bacteriology, National Institute for Research in Tuberculosis, Chennai, 600 031, India.
Rahul MaitraDepartment of Molecular Microbiology & Immunology, CSIR - Central Drug Research Institute, Sitapur Road, Janakipuram Extension, Lucknow, Uttar Pradesh, 226 031, India.
Sidharth ChopraAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201 002, India.
Sunil MisraAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201 002, India.
Haridas B RodeDepartment of Natural Products & Medicinal Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.ORCID 0000-0003-3958-1802

Funding

Indian Council of Medical Research 5/8/34/ITR-F/2020-ITR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsMicrobial Sensitivity TestsMycobacterium tuberculosisPyridinesAnimalsChlorocebus aethiopsCHO CellsCricetulusDrug Resistance, BacterialHumansMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipVero CellsAntitubercular AgentsPyridines3,5-disubstituted pyridineantituberculosis agentsDprE1 inhibitorsdrug-resistant tuberculosismycobacterium H37Rv

Identifiers

PMID39363626
PMCPMC11622763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.